3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
12
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
von Hippel-Lindau Disease
2
Pheochromocytoma
1
Paraganglioma
1
Kidney Neoplasms
1
Carcinoma
1
Breast Neoplasms
1
Adenoma, Islet Cell
1
Interventions
Specimen Handling
40
Biopsy
32
Magnetic Resonance Spectroscopy
26
pembrolizumab
20
Nivolumab
10
trastuzumab deruxtecan
9
Paclitaxel
9
Carboplatin
9
Radiosurgery
7
Irinotecan
7
Gemcitabine
7
X-Rays
6
Pemetrexed
6
Leucovorin
6
Ipilimumab
6
Fulvestrant
6
Fluorouracil
6
Cetuximab
6
Bevacizumab
6
palbociclib
5
Taxes
5
Oxaliplatin
5
Cisplatin
5
Capecitabine
5
130-nm albumin-bound paclitaxel
5
durvalumab
4
Letrozole
4
CTLA-4 Antigen
4
ribociclib
3
olaparib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
belzutifan
×
30 days
×
Clear all
No trials found.